• Care Mag Search: Diabetes

      Receive the "Wellness" Newsletter by email

  • Sanofi Is Now the Third Insulin Producer to Slash Prices

    13 days ago - By Time

    Sanofi will cut the U.S. list price of two of its insulins, making it the third major producer of the diabetes medicine to recently slash prices.
    French pharmaceutical maker Sanofi will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%, according to a statement Thursday. The company will also reduce the list price of Apidra by 70%.
    “We are pleased to see others join our efforts to help patients as we now accelerate the transformation of the U.S. insulin market,” said Olivier Bogillot, the head of U.S. general medicines. “Our decision to cut the list price of our...
    Read more ...

     

  • STAT+: Pharmalittle: Sanofi cuts price on a popular insulin by 78%; Califf criticizes insurers for doing too little on drug research

    13 days ago - By STAT

    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to promenade with the official mascot, catch up on our napping, and hope to have a listening party with Mrs. Pharmalot. So far, the rotation includes this , this and this. And what about you? Spring is about to spring, so this may be an opportunity to start tidying up around the castle. You could get a head start and book a much-needed getaway, or curl up in front of the telly and binge...
    Read more ...